Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 5 IN WATER versus SORBITOL MANNITOL IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 5 IN WATER versus SORBITOL MANNITOL IN PLASTIC CONTAINER.
OSMITROL 5% IN WATER vs SORBITOL-MANNITOL IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular and interstitial spaces into the extracellular compartment, thereby reducing cerebral edema and intraocular pressure; also promotes diuresis by increasing renal tubular fluid osmolality.
Sorbitol and mannitol are osmotic diuretics. They increase osmotic pressure in the glomerular filtrate, reducing water reabsorption and promoting diuresis. Mannitol also decreases intracranial and intraocular pressure by creating an osmotic gradient that draws water from tissues into the vasculature.
50-100 g intravenously as a 5% solution over 30-60 minutes; may repeat every 6-8 hours as needed. Maximum dose: 200 g in 24 hours.
Intravenous infusion of 50 mL of a 25% sorbitol-25% mannitol solution administered over 10–20 minutes; may repeat once after 6–8 hours if needed.
None Documented
None Documented
Approximately 0.25-1.5 hours (15-90 minutes); prolonged in renal impairment or with mannitol accumulation (e.g., in anuria).
Sorbitol: approximately 0.5-1 hour; mannitol: approximately 0.5-1.5 hours. In anuria, mannitol half-life may extend to 36 hours.
Primarily renal (90-100% unchanged in urine); negligible biliary or fecal elimination.
Renal: >95% as unchanged sorbitol and mannitol; negligible biliary/fecal elimination.
Category C
Category A/B
Osmotic Diuretic
Osmotic Diuretic